Featured
-
ERA-EDTA Congress 2019
Check out the latest news from the European Renal Association-European Dialysis and Transplant Association’s 56th Congress in Budapest, Hungary. -
Pharmacologic Therapy for CRPC
At the 2019 annual meeting of the American Urological Association (AUA), Dr Jarrard was a member of the instructional faculty in a session titled “AUA Castration Resistant Prostate Cancer (CRPC) Guidelines and Therapeutic Advances in Metastatic Prostate Cancer.” -
Post-Nephrectomy AKI Harms Long-Term Renal Functional Recovery
The risk of negative renal outcomes, including CKD upgrading, increases along with duration of acute kidney injury following partial nephrectomy -
Prostate Cancer Recurrence Risk Higher With Extensive Positive Margins
In a study, just 12.1% of cases with focal positive surgical margins (PSM) experienced biochemical recurrence compared with 54.1% of those with extensive PSM. -
American Transplant Congress 2019
Check out the latest news from the American Transplant Congress annual meeting. -
SABR May Up Survival in Oligometastatic Cancers
New data from a phase 2 randomized trial suggest that stereotactic ablative radiotherapy to sites of metastases may prolong overall and progression-free survival. -
Don’t Forget About State Laws on HIPAA Breaches
More and more states have enacted laws calling for stricter breach-reporting requirements than HIPAA -
Embrace, Don’t Fear, Price Transparency
Letting patients know the prices of health care services in advance can increase practice income and engender patient loyalty. -
Responding to Patients’ Discriminatory Comments
Health care professionals have the right to protect themselves from unjust discrimination, but doing so should not interfere with their professional commitments to promote patient’s access to care, even when patients exhibit objectionable behavior.
Latest Nephrology News
1 in 5 Surgeons Not Meeting AVF Placement Goal
Combination Treatment of SGLT2 Inhibitor and Exenatide May Improve Renal and Mortality Outcomes
Dulaglutide Reduces CV Events, Renal Progression in Type 2 Diabetes
Latest Urology News
Adverse Events Associated With Outcomes in PD-1/PD-L1–Treated Urothelial Carcinoma
Darolutamide Delays Pain Progression, Deterioration in Urinary Symptoms in High-Risk Nonmetastatic CRPC
